Immucell Corp (ICCC) Reports Q1 EPS of $0.21 May 14, 2026 04:21PM
ImmuCell reports 28% sales increase in first quarter 2026 Apr 8, 2026 04:05PM
Immucell Corp (ICCC) Reports Q4 Loss of $0.31 Mar 4, 2026 04:08PM
ImmuCell reports mixed Q4 2025 results, pauses Re-Tain development Jan 8, 2026 04:08PM
ImmuCell pauses Re-Tain development after FDA rejection, shifts to First Defense Dec 24, 2025 01:06PM


Nov 13, 2025 04:41PM Immucell Corp (ICCC) Reports Q3 Loss of $0.02
Sep 29, 2025 04:06PM ImmuCell names Olivier te Boekhorst as next president and CEO
Aug 14, 2025 04:14PM Immucell Corp (ICCC) Reports Q2 EPS of $0.06
Aug 12, 2025 04:08PM ImmuCell refinances bank debt with lower interest rate
Jul 9, 2025 08:01AM ImmuCell reports 18% sales growth in Q2 2025
Jun 25, 2025 08:00AM Immucell Corp (ICCC) Seeking new CEO
May 14, 2025 04:12PM Immucell Corp (ICCC) Reports Q1 EPS of $0.16
Apr 8, 2025 04:06PM Immucell Corp (ICCC) Reports Prelim Q1 Sales
Apr 7, 2025 09:00AM Immucell Corp (ICCC) Appoints Timothy C. Fiori as CFO
Feb 25, 2025 04:21PM Immucell Corp (ICCC) Reports Q4 EPS of $0.06
Jan 16, 2025 04:06PM Immucell Corp (ICCC) Announces Settlement of Insurance Claim Related to Previously Disclosed Production Contamination Losses
Nov 13, 2024 04:19PM Immucell Corp (ICCC) Reports Q3 Loss of $0.09
Oct 8, 2024 04:07PM Immucell Corp (ICCC) Reports Prelim Q3 Results
Aug 13, 2024 04:08PM Immucell Corp (ICCC) Reports Q2 Loss of $0.20
Jul 9, 2024 04:11PM Immucell Corp (ICCC) Announces Preliminary Sales Results for Q2